Profile
Rainer Sturm worked as a Principal at Bertelsmann SE & Co. KGaA, Vice President-Finance at The Global Life Science Ventures GmbH, and Chief Financial Officer & Senior Vice President at numares AG from 2013 to 2018.
Former positions of Rainer Sturm
| Companies | Position | End |
|---|---|---|
numares AG
numares AG Medical SpecialtiesHealth Technology Develops and markets medical tests for diagnostics and therapy monitoring | Director of Finance/CFO | 31/08/2018 |
The Global Life Science Ventures GmbH
The Global Life Science Ventures GmbH Investment ManagersFinance GLSV is an active, long-term manager which aims to create and build value exclusively in life science companies in the UK, Switzerland, German-speaking countries and the US. They invest in many areas of the life sciences including the cancer, immunology, vaccines, biopharmaceuticals, indication-specific genomics, genomics tools, diagnostics, medical devices, healthcare services and cardiovascular areas. The firm primarily invests in early-stage companies that operate in significant markets with considerable upside potential, as well as in later-stage companies, including buyouts, which meet their investment in their home markets, GLSV is the lead investor or an active co-investor, while outside of their home markets they only act as a knowledgeable co-investor. | Director of Finance/CFO | - |
| BERTELSMANN SE & CO. KGAA | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Bertelsmann SE & Co. KGaA
Bertelsmann SE & Co. KGaA Movies/EntertainmentConsumer Services Provides entertainment, radio broadcasting, book publishing, music and education services | Consumer Services |
The Global Life Science Ventures GmbH
The Global Life Science Ventures GmbH Investment ManagersFinance GLSV is an active, long-term manager which aims to create and build value exclusively in life science companies in the UK, Switzerland, German-speaking countries and the US. They invest in many areas of the life sciences including the cancer, immunology, vaccines, biopharmaceuticals, indication-specific genomics, genomics tools, diagnostics, medical devices, healthcare services and cardiovascular areas. The firm primarily invests in early-stage companies that operate in significant markets with considerable upside potential, as well as in later-stage companies, including buyouts, which meet their investment in their home markets, GLSV is the lead investor or an active co-investor, while outside of their home markets they only act as a knowledgeable co-investor. | Finance |
numares AG
numares AG Medical SpecialtiesHealth Technology Develops and markets medical tests for diagnostics and therapy monitoring | Health Technology |
- Stock Market
- Insiders
- Rainer Sturm
















